- Amended Statement of Beneficial Ownership (3/A)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

ASHMAN HARVEY A.

2. Date of Event Requiring Statement (MM/DD/YYYY) 10/1/2009

3. Issuer Name and Ticker or Trading Symbol

IMS HEALTH INC [RX]

(Last) (First) (Middle)

C/O IMS HEALTH, 901 MAIN AVENUE, SUITE 612

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
SVP, Gen Counsel & Ext Affairs /

(Street)

NORWALK, CT 06851

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

10/5/2009

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7959	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (Right to Buy)	⁽¹⁾	2/15/2010	Common Stock	25622	$20.49	D
Option (Right to Buy)	⁽²⁾	4/5/2011	Common Stock	35000	$23.92	D
Option (Right to Buy)	⁽³⁾	4/15/2012	Common Stock	24000	$24.06	D
Stock Appreciation Right	⁽⁴⁾	4/15/2015	Common Stock	15027	$22.58	D
Stock Appreciation Right	⁽⁵⁾	4/21/2016	Common Stock	20604	$13.43	D

Explanation of Responses:
( 1)	This option vests in three equal annual installments beginning on 2/15/2001.
( 2)	This option vests in three equal annual installments beginning on 4/5/2005.
( 3)	This option vests in three equal annual installments beginning on 4/15/2006.
( 4)	This Stock Appreciation Right vests in four equal annual installments beginning on 4/15/2009.
( 5)	This Stock Appreciation Right vests in three equal annual installments beginning on 4/21/2010.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
ASHMAN HARVEY A. C/O IMS HEALTH 901 MAIN AVENUE, SUITE 612 NORWALK, CT 06851			SVP, Gen Counsel & Ext Affairs

Signatures
/s/ Harvey A. Ashman		12/2/2009
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.